Comparative evaluation of Levetiracetam 1000 mg extended release tablet once daily formulation with  Levetiracetam 500 mg immediate release tablet twice daily formulation by assessing pharmacokinetic parameters in healthy human subjects

dc.contributor.guide	Marwah, Amit and Monif, Tausif	en_US
dc.coverage.spatial		en_US
dc.creator.researcher	Mehra, Sachin	en_US
dc.date.accessioned	2015-04-24T12:54:05Z
dc.date.available	2015-04-24T12:54:05Z
dc.date.awarded	2013	en_US
dc.date.completed	2013	en_US
dc.date.issued	2015-04-24
dc.date.registered	2009	en_US
dc.description.abstract	newline	en_US
dc.description.note		en_US
dc.format.accompanyingmaterial	DVD	en_US
dc.format.dimensions		en_US
dc.format.extent		en_US
dc.identifier.uri	http://hdl.handle.net/10603/39729
dc.language	English	en_US
dc.publisher.institution	Department of Pharmaceutical Chemistry	en_US
dc.publisher.place	Delhi	en_US
dc.publisher.university	Jamia Hamdard University	en_US
dc.relation		en_US
dc.rights	university	en_US
dc.source.university	University	en_US
dc.title	Comparative evaluation of Levetiracetam 1000 mg extended release tablet once daily formulation with Levetiracetam 500 mg immediate release tablet twice daily formulation by assessing pharmacokinetic parameters in healthy human subjects	en_US
dc.title.alternative	an initial step towards improving patient compliance	en_US
dc.type.degree	Ph.D.	en_US